A once-daily, oral, hormonal treatment for metastatic, castration-resistant, prostate cancer in men who have previously received docetaxel.
Emerging Technology Reports
The Emerging Technology Report provides regular updates about emerging and potentially disruptive technologies that are likely to have a significant impact in healthcare. This “early warning” report monitors new health technologies from 6 months to 2 years within a regulatory submission and tracks those as they go through clinical trial development and the regulatory approval process.
For each emerging technology, our analysts describe the technology and intended use, its prospects relative to the regulatory process and FDA information, competing technologies, relevant clinical guidelines, high-level look at the evidence such as published abstracts in the medical literature and available meeting abstracts, and available clinical trials.
Selenia® Dimensions® Digital Tomosynthesis System
A three-dimensional breast imaging system that uses a rotating x-ray tube to acquire multiple images of the breast from several angles, intended for use as an adjunct or replacement for screen-film and digital mammography.
Linzess™ (Linaclotide)
A once-daily oral treatment for irritable bowel syndrome with constipation, as well as chronic constipation.
Marqibo® (Vincristine Sulfate Liposome Injection)
Nanoparticle-based encapsulated vincristine injection for the treatment of advanced relapsed and/or refractory Philadelphia chromosome-negative adult acute lymphoblastic leukemia.
Bapineuzumab (AAB-001)
An intravenous passive immunotherapy for the treatment of patients with mild to moderate Alzheimer’s disease.
CorPath® 200 System
A robotic-assisted system for guiding percutaneous coronary intervention procedures used in conjunction with an interventional fluoroscopic imaging system, intended to reduce operator radiation exposure and procedure-related fatigue.
Kyprolis™ (Carfilzomib)
An intravenous, next-generation proteasome inhibitor for third-line treatment of multiple myeloma.
Resolute Integrity™ Zotarolimus-Eluting Coronary Stent
A zotarolimus-eluting stent coated with BioLinx, a biocompatible proprietary polymer blend with hydrophilic and noninflammatory properties, designed to extend the delivery time of zotarolimus to the vessel wall to treat complex lesions that may have delayed healing time and greater prolonged risk for restenosis.
Afinitor® (Everolimus) for Breast Cancer
A novel oral agent for HER2-negative advanced or metastatic breast cancer resistant to aromatase inhibitors.
Magnetoencephalography (MEG) for Posttraumatic Stress Disorder (PTSD)
An imaging system that measures magnetic fields produced by the brain’s electrical activity; under investigation for the diagnosis of posttraumatic stress disorder.